| abstract |
"Hetererocyclic Aminoalkylpyridine Derivatives as Psychopharmaceuticals". The invention relates to heterocyclic aminoalkylpyridine derivatives of formula I wherein R1 is the radical of a heterocycle having from 1 to 3 ring structures, where each ring structure is saturated, unsaturated or aromatic and optionally fused to other ring structures. ring structures to provide a fused ring system, and the heterocycle has a total of 1 to 4 N, O and / or S atoms in the ring structures and is optionally monosubstituted, disubstituted or trisubstituted by one or more of the groups - A, -OR ^ 4 ^ -N (R ^ 4 ^) -2 ~, -NO-2 ~, -CN, Hal, -COOR ^ 4 ^, -CON (R ^ 4 ^) ~ 2 ~, -COR ^ 4 ^, = O; R 2 is a phenyl group which is optionally monosubstituted, disubstituted, trisubstituted, tetrasubstituted or penta-substituted by one or more of the groups Hal, -A, -OA, -NO-2 ~ or -CN, or is a thienyl group which is optionally monosubstituted or disubstituted by one or more of the groups Hal, -A, -OA, -NO-2-, -CN or thienyl; R 3 is H, -A, -CO-A, -C (R 4 R 4) -2-R 2 R 2 -C-R 2 -pyridinediyl-R 2 R 2; R4 is H or -A; A is C 1-6 -C 6 alkyl where from 1 to 7 hydrogen atoms are optionally substituted by fluorine; -X- is -O-, -S-, sulfinyl, sulfonyl, -C (R 4 R 4) -2-; -Y- is - [C (R 4 R 4) ~ 2 ~] ~ n ~ -; -Z- is -C (R 4 R 4) -2- -; Hal is F, CI, Br or I; n is 1, 2, 3 or 4; and their tolerable salts and solvates and their use as medicaments. New page 1 of claim table incorporating amendments to claims as per Preliminary Review report. |